newsfilter
← Latest News
GlobeNewswire·

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2022

NEW HAVEN, Conn., Oct. 28, 2022 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI, OTCQB:BIOAF), (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company developing clinical